细粒度特征是帕金森病中海马和杏仁体变化模式的特征,并区分认知缺陷亚型
Lingyu Zhang1, Pengfei Zhang2,3, Qunxi Dong4
1Gansu Provincial Key Laboratory of Wearable Computing, School of Information Science and Engineering, Lanzhou University, Lanzhou, China.
CNS neuroscience & therapeutics
|October 18, 2023
概括
轻度认知障碍 (PD-MCI) 的帕金森病显示出显著的杏仁体变化和微妙的海马缩. 这些大脑变化可能作为诊断PD-MCI的生物标志物.
科学领域:
- 神经成像是一种神经成像.
- 神经学 神经学
- 认知科学 认知科学
背景情况:
- 帕金森病 (PD) 可以导致轻度认知障碍 (MCI),影响皮层下结构.
- 了解海马体和杏仁体的形态变化对于PD-MCI诊断至关重要.
研究的目的:
- 在患有MCI (PD-MCI) 和正常认知 (PD-NC) 的PD中提取海马和杏仁体的顶点智能特征.
- 评估这些特征对PD-MCI诊断的歧视性有效性.
主要方法:
- 来自PD-MCI,PD-NC和健康对照 (HC) 的高分辨率3D-T1MRI数据.
- 表面形状表示和流体注册,用于捕捉表面的几何特征.
- 统计测试和集体分类器用于检测群体差异和评估歧视能力.
主要成果:
- 杏仁体,而不是海马体,显示出显著的群体差异.
- 与PD-NC相比,PD-MCI患者在特定的亚区域表现出杏仁体扩张和缩.
- 在PD-MCI患者的右CA1和海马体体内观察到微妙的缩.
- 使用形态特征的分类器实现了超过85%的准确性.
结论:
- PD-MCI与杏仁体的多层次形态变化和微妙的海马缩有关.
- 这些新的指标显示了PD-MCI诊断的生物标志物的潜力.
- 这些发现增强了对皮质下结构在PD认知障碍中的作用的理解.
更多相关视频
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.9K
14:27Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
15.7K
相关概念视频
Parkinson's Disease: Overview
567
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
567
Alzheimer's Disease: Overview
500
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
500
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
